Trials / Conditions / Stage II Renal Cell Cancer AJCC v8
Stage II Renal Cell Cancer AJCC v8
5 registered clinical trials studyying Stage II Renal Cell Cancer AJCC v8 — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer NCT07226544 | City of Hope Medical Center | Phase 2 |
| Not Yet Recruiting | Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Cl NCT07516366 | National Cancer Institute (NCI) | Phase 2 |
| Not Yet Recruiting | Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Su NCT07037004 | City of Hope Medical Center | Phase 2 |
| Withdrawn | MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial NCT04580836 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913 | City of Hope Medical Center | — |